nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—Papaverine—PDE3B—polycystic ovary syndrome	0.0205	0.752	CrCbGaD
Verapamil—Emotional distress—Metformin—polycystic ovary syndrome	0.0141	0.0984	CcSEcCtD
Verapamil—CYP2C19—urine—polycystic ovary syndrome	0.00793	0.0256	CbGeAlD
Verapamil—Contusion—Metformin—polycystic ovary syndrome	0.00686	0.0479	CcSEcCtD
Verapamil—Accidental injury—Metformin—polycystic ovary syndrome	0.00676	0.0473	CcSEcCtD
Verapamil—CYP1A2—urine—polycystic ovary syndrome	0.00648	0.0209	CbGeAlD
Verapamil—CYP2C9—urine—polycystic ovary syndrome	0.00615	0.0199	CbGeAlD
Verapamil—CACNA1B—pituitary gland—polycystic ovary syndrome	0.0061	0.0197	CbGeAlD
Verapamil—CACNA1A—adrenal gland—polycystic ovary syndrome	0.00558	0.018	CbGeAlD
Verapamil—CACNB3—endometrium—polycystic ovary syndrome	0.00554	0.0179	CbGeAlD
Verapamil—CACNB4—vagina—polycystic ovary syndrome	0.00542	0.0175	CbGeAlD
Verapamil—CACNB1—adipose tissue—polycystic ovary syndrome	0.0052	0.0168	CbGeAlD
Verapamil—CACNB3—uterus—polycystic ovary syndrome	0.0051	0.0165	CbGeAlD
Verapamil—CACNB3—pituitary gland—polycystic ovary syndrome	0.00501	0.0162	CbGeAlD
Verapamil—CACNB3—adipose tissue—polycystic ovary syndrome	0.00499	0.0161	CbGeAlD
Verapamil—Injury—Metformin—polycystic ovary syndrome	0.00472	0.033	CcSEcCtD
Verapamil—CYP3A4—urine—polycystic ovary syndrome	0.00469	0.0151	CbGeAlD
Verapamil—CACNB1—adrenal gland—polycystic ovary syndrome	0.00467	0.0151	CbGeAlD
Verapamil—CYP2D6—urine—polycystic ovary syndrome	0.00461	0.0149	CbGeAlD
Verapamil—CACNB3—adrenal gland—polycystic ovary syndrome	0.00448	0.0145	CbGeAlD
Verapamil—Lethargy—Metformin—polycystic ovary syndrome	0.00443	0.031	CcSEcCtD
Verapamil—CACNB1—female gonad—polycystic ovary syndrome	0.00435	0.0141	CbGeAlD
Verapamil—Bevantolol—ADRA1A—polycystic ovary syndrome	0.00424	0.155	CrCbGaD
Verapamil—CACNB3—female gonad—polycystic ovary syndrome	0.00418	0.0135	CbGeAlD
Verapamil—CACNB3—vagina—polycystic ovary syndrome	0.00415	0.0134	CbGeAlD
Verapamil—Cramp muscle—Metformin—polycystic ovary syndrome	0.00391	0.0273	CcSEcCtD
Verapamil—Influenza—Metformin—polycystic ovary syndrome	0.00375	0.0262	CcSEcCtD
Verapamil—Sweating increased—Metformin—polycystic ovary syndrome	0.00366	0.0256	CcSEcCtD
Verapamil—Angina pectoris—Metformin—polycystic ovary syndrome	0.00366	0.0256	CcSEcCtD
Verapamil—CACNA1D—adrenal cortex—polycystic ovary syndrome	0.00364	0.0118	CbGeAlD
Verapamil—CACNA1H—uterus—polycystic ovary syndrome	0.00363	0.0117	CbGeAlD
Verapamil—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0036	0.0252	CcSEcCtD
Verapamil—CACNA1H—pituitary gland—polycystic ovary syndrome	0.00357	0.0115	CbGeAlD
Verapamil—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00349	0.0244	CcSEcCtD
Verapamil—CACNB2—pituitary gland—polycystic ovary syndrome	0.00337	0.0109	CbGeAlD
Verapamil—Drowsiness—Metformin—polycystic ovary syndrome	0.00335	0.0234	CcSEcCtD
Verapamil—CYP2C18—vagina—polycystic ovary syndrome	0.00331	0.0107	CbGeAlD
Verapamil—CACNA1H—adrenal gland—polycystic ovary syndrome	0.00319	0.0103	CbGeAlD
Verapamil—CYP2C18—endocrine gland—polycystic ovary syndrome	0.00309	0.01	CbGeAlD
Verapamil—ABCC3—adrenal cortex—polycystic ovary syndrome	0.00306	0.00989	CbGeAlD
Verapamil—Bradycardia—Metformin—polycystic ovary syndrome	0.00306	0.0214	CcSEcCtD
Verapamil—ABCC10—adrenal cortex—polycystic ovary syndrome	0.00304	0.00984	CbGeAlD
Verapamil—Rhinitis—Metformin—polycystic ovary syndrome	0.00301	0.0211	CcSEcCtD
Verapamil—ABCB11—endocrine gland—polycystic ovary syndrome	0.00301	0.00972	CbGeAlD
Verapamil—CACNB2—adrenal gland—polycystic ovary syndrome	0.00301	0.00972	CbGeAlD
Verapamil—Hepatitis—Metformin—polycystic ovary syndrome	0.003	0.021	CcSEcCtD
Verapamil—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00299	0.0209	CcSEcCtD
Verapamil—CACNA1H—female gonad—polycystic ovary syndrome	0.00297	0.0096	CbGeAlD
Verapamil—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00296	0.0207	CcSEcCtD
Verapamil—CACNA1D—pituitary gland—polycystic ovary syndrome	0.00294	0.00951	CbGeAlD
Verapamil—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00294	0.00951	CbGeAlD
Verapamil—KCNJ11—adrenal gland—polycystic ovary syndrome	0.00285	0.00923	CbGeAlD
Verapamil—Flushing—Metformin—polycystic ovary syndrome	0.00279	0.0195	CcSEcCtD
Verapamil—CACNB2—vagina—polycystic ovary syndrome	0.00279	0.00901	CbGeAlD
Verapamil—CACNA1H—endocrine gland—polycystic ovary syndrome	0.00276	0.00893	CbGeAlD
Verapamil—ABCC10—endometrium—polycystic ovary syndrome	0.00272	0.00878	CbGeAlD
Verapamil—CACNA1C—pituitary gland—polycystic ovary syndrome	0.00272	0.00878	CbGeAlD
Verapamil—CACNA1C—adipose tissue—polycystic ovary syndrome	0.00271	0.00875	CbGeAlD
Verapamil—KCNJ11—female gonad—polycystic ovary syndrome	0.00266	0.0086	CbGeAlD
Verapamil—CACNA1D—adrenal gland—polycystic ovary syndrome	0.00263	0.0085	CbGeAlD
Verapamil—SLC22A4—endometrium—polycystic ovary syndrome	0.00256	0.00826	CbGeAlD
Verapamil—Bevantolol—ADRB2—polycystic ovary syndrome	0.00252	0.0924	CrCbGaD
Verapamil—Muscle spasms—Metformin—polycystic ovary syndrome	0.00251	0.0176	CcSEcCtD
Verapamil—ABCC10—uterus—polycystic ovary syndrome	0.0025	0.00809	CbGeAlD
Verapamil—KCNJ11—endocrine gland—polycystic ovary syndrome	0.00248	0.008	CbGeAlD
Verapamil—Vision blurred—Metformin—polycystic ovary syndrome	0.00246	0.0172	CcSEcCtD
Verapamil—ABCC3—adipose tissue—polycystic ovary syndrome	0.00246	0.00796	CbGeAlD
Verapamil—ABCC10—pituitary gland—polycystic ovary syndrome	0.00246	0.00795	CbGeAlD
Verapamil—Tremor—Metformin—polycystic ovary syndrome	0.00245	0.0171	CcSEcCtD
Verapamil—ABCC10—adipose tissue—polycystic ovary syndrome	0.00245	0.00792	CbGeAlD
Verapamil—CACNA1C—adrenal gland—polycystic ovary syndrome	0.00243	0.00784	CbGeAlD
Verapamil—Syncope—Metformin—polycystic ovary syndrome	0.00235	0.0164	CcSEcCtD
Verapamil—SLC22A4—pituitary gland—polycystic ovary syndrome	0.00231	0.00747	CbGeAlD
Verapamil—Palpitations—Metformin—polycystic ovary syndrome	0.00231	0.0162	CcSEcCtD
Verapamil—SLC22A4—adipose tissue—polycystic ovary syndrome	0.0023	0.00744	CbGeAlD
Verapamil—Loss of consciousness—Metformin—polycystic ovary syndrome	0.0023	0.0161	CcSEcCtD
Verapamil—CACNA1D—endocrine gland—polycystic ovary syndrome	0.00228	0.00737	CbGeAlD
Verapamil—Hypertension—Metformin—polycystic ovary syndrome	0.00226	0.0158	CcSEcCtD
Verapamil—CACNA1C—vagina—polycystic ovary syndrome	0.00225	0.00727	CbGeAlD
Verapamil—Myalgia—Metformin—polycystic ovary syndrome	0.00223	0.0156	CcSEcCtD
Verapamil—Chest pain—Metformin—polycystic ovary syndrome	0.00223	0.0156	CcSEcCtD
Verapamil—ABCC3—adrenal gland—polycystic ovary syndrome	0.00221	0.00714	CbGeAlD
Verapamil—Discomfort—Metformin—polycystic ovary syndrome	0.0022	0.0154	CcSEcCtD
Verapamil—ABCC10—adrenal gland—polycystic ovary syndrome	0.0022	0.0071	CbGeAlD
Verapamil—SLC22A1—adipose tissue—polycystic ovary syndrome	0.00219	0.00709	CbGeAlD
Verapamil—SCN5A—vagina—polycystic ovary syndrome	0.00218	0.00704	CbGeAlD
Verapamil—ABCC1—adrenal cortex—polycystic ovary syndrome	0.00215	0.00696	CbGeAlD
Verapamil—Oedema—Metformin—polycystic ovary syndrome	0.00213	0.0149	CcSEcCtD
Verapamil—Infection—Metformin—polycystic ovary syndrome	0.00212	0.0148	CcSEcCtD
Verapamil—CACNA1C—endocrine gland—polycystic ovary syndrome	0.0021	0.0068	CbGeAlD
Verapamil—Shock—Metformin—polycystic ovary syndrome	0.0021	0.0147	CcSEcCtD
Verapamil—ABCC4—uterus—polycystic ovary syndrome	0.00208	0.00671	CbGeAlD
Verapamil—SLC22A4—adrenal gland—polycystic ovary syndrome	0.00207	0.00668	CbGeAlD
Verapamil—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00206	0.0144	CcSEcCtD
Verapamil—ABCC3—female gonad—polycystic ovary syndrome	0.00206	0.00665	CbGeAlD
Verapamil—ABCC10—female gonad—polycystic ovary syndrome	0.00205	0.00662	CbGeAlD
Verapamil—ABCC10—vagina—polycystic ovary syndrome	0.00204	0.00658	CbGeAlD
Verapamil—ABCC4—adipose tissue—polycystic ovary syndrome	0.00203	0.00657	CbGeAlD
Verapamil—SLCO1B1—endocrine gland—polycystic ovary syndrome	0.00202	0.00652	CbGeAlD
Verapamil—Hypotension—Metformin—polycystic ovary syndrome	0.00199	0.0139	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00194	0.0136	CcSEcCtD
Verapamil—ABCC1—endometrium—polycystic ovary syndrome	0.00192	0.00621	CbGeAlD
Verapamil—Paraesthesia—Metformin—polycystic ovary syndrome	0.00192	0.0134	CcSEcCtD
Verapamil—ABCC3—endocrine gland—polycystic ovary syndrome	0.00191	0.00619	CbGeAlD
Verapamil—SLC22A4—vagina—polycystic ovary syndrome	0.00191	0.00619	CbGeAlD
Verapamil—ABCC10—endocrine gland—polycystic ovary syndrome	0.00191	0.00616	CbGeAlD
Verapamil—Dyspnoea—Metformin—polycystic ovary syndrome	0.0019	0.0133	CcSEcCtD
Verapamil—Somnolence—Metformin—polycystic ovary syndrome	0.0019	0.0133	CcSEcCtD
Verapamil—SLC22A5—adrenal cortex—polycystic ovary syndrome	0.00189	0.00612	CbGeAlD
Verapamil—Dyspepsia—Metformin—polycystic ovary syndrome	0.00188	0.0131	CcSEcCtD
Verapamil—Fatigue—Metformin—polycystic ovary syndrome	0.00184	0.0129	CcSEcCtD
Verapamil—Constipation—Metformin—polycystic ovary syndrome	0.00183	0.0128	CcSEcCtD
Verapamil—SLC22A1—vagina—polycystic ovary syndrome	0.00182	0.00589	CbGeAlD
Verapamil—ABCC4—adrenal gland—polycystic ovary syndrome	0.00182	0.00589	CbGeAlD
Verapamil—KCNH2—endometrium—polycystic ovary syndrome	0.00179	0.00578	CbGeAlD
Verapamil—ABCG2—adrenal cortex—polycystic ovary syndrome	0.00178	0.00576	CbGeAlD
Verapamil—ABCC1—uterus—polycystic ovary syndrome	0.00177	0.00573	CbGeAlD
Verapamil—ABCC2—adrenal gland—polycystic ovary syndrome	0.00176	0.0057	CbGeAlD
Verapamil—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00176	0.0123	CcSEcCtD
Verapamil—ABCC1—pituitary gland—polycystic ovary syndrome	0.00174	0.00562	CbGeAlD
Verapamil—ABCC1—adipose tissue—polycystic ovary syndrome	0.00173	0.0056	CbGeAlD
Verapamil—SLC22A1—endocrine gland—polycystic ovary syndrome	0.00171	0.00551	CbGeAlD
Verapamil—ABCC4—female gonad—polycystic ovary syndrome	0.0017	0.00549	CbGeAlD
Verapamil—Urticaria—Metformin—polycystic ovary syndrome	0.0017	0.0119	CcSEcCtD
Verapamil—SLC22A5—endometrium—polycystic ovary syndrome	0.00169	0.00546	CbGeAlD
Verapamil—KCNH2—uterus—polycystic ovary syndrome	0.00165	0.00533	CbGeAlD
Verapamil—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00164	0.00531	CbGeAlD
Verapamil—SLCO1A2—endocrine gland—polycystic ovary syndrome	0.00164	0.00531	CbGeAlD
Verapamil—CYP2C8—endometrium—polycystic ovary syndrome	0.00164	0.00529	CbGeAlD
Verapamil—KCNH2—pituitary gland—polycystic ovary syndrome	0.00162	0.00523	CbGeAlD
Verapamil—ABCG2—endometrium—polycystic ovary syndrome	0.00159	0.00514	CbGeAlD
Verapamil—SLC6A4—endocrine gland—polycystic ovary syndrome	0.00159	0.00513	CbGeAlD
Verapamil—ABCC4—endocrine gland—polycystic ovary syndrome	0.00158	0.00511	CbGeAlD
Verapamil—ABCC1—adrenal gland—polycystic ovary syndrome	0.00155	0.00502	CbGeAlD
Verapamil—Asthenia—Metformin—polycystic ovary syndrome	0.00153	0.0107	CcSEcCtD
Verapamil—SLC22A5—pituitary gland—polycystic ovary syndrome	0.00153	0.00494	CbGeAlD
Verapamil—ABCC2—endocrine gland—polycystic ovary syndrome	0.00153	0.00494	CbGeAlD
Verapamil—SLC22A5—adipose tissue—polycystic ovary syndrome	0.00152	0.00492	CbGeAlD
Verapamil—Pruritus—Metformin—polycystic ovary syndrome	0.00151	0.0106	CcSEcCtD
Verapamil—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00148	0.00479	CbGeAlD
Verapamil—ABCG2—uterus—polycystic ovary syndrome	0.00147	0.00474	CbGeAlD
Verapamil—Diarrhoea—Metformin—polycystic ovary syndrome	0.00146	0.0102	CcSEcCtD
Verapamil—ABCC1—female gonad—polycystic ovary syndrome	0.00145	0.00468	CbGeAlD
Verapamil—KCNH2—adrenal gland—polycystic ovary syndrome	0.00145	0.00467	CbGeAlD
Verapamil—ABCC1—vagina—polycystic ovary syndrome	0.00144	0.00465	CbGeAlD
Verapamil—ABCG2—pituitary gland—polycystic ovary syndrome	0.00144	0.00465	CbGeAlD
Verapamil—ABCG2—adipose tissue—polycystic ovary syndrome	0.00143	0.00464	CbGeAlD
Verapamil—Dizziness—Metformin—polycystic ovary syndrome	0.00141	0.00987	CcSEcCtD
Verapamil—CYP2C19—vagina—polycystic ovary syndrome	0.00141	0.00454	CbGeAlD
Verapamil—SLC22A5—adrenal gland—polycystic ovary syndrome	0.00137	0.00442	CbGeAlD
Verapamil—Vomiting—Metformin—polycystic ovary syndrome	0.00136	0.00949	CcSEcCtD
Verapamil—KCNH2—female gonad—polycystic ovary syndrome	0.00135	0.00436	CbGeAlD
Verapamil—Rash—Metformin—polycystic ovary syndrome	0.00135	0.00941	CcSEcCtD
Verapamil—Dermatitis—Metformin—polycystic ovary syndrome	0.00134	0.0094	CcSEcCtD
Verapamil—KCNH2—vagina—polycystic ovary syndrome	0.00134	0.00433	CbGeAlD
Verapamil—Headache—Metformin—polycystic ovary syndrome	0.00134	0.00935	CcSEcCtD
Verapamil—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00133	0.0043	CbGeAlD
Verapamil—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00131	0.00425	CbGeAlD
Verapamil—ABCG2—adrenal gland—polycystic ovary syndrome	0.00129	0.00416	CbGeAlD
Verapamil—SLC22A5—female gonad—polycystic ovary syndrome	0.00127	0.00412	CbGeAlD
Verapamil—Nausea—Metformin—polycystic ovary syndrome	0.00127	0.00887	CcSEcCtD
Verapamil—SLC22A5—vagina—polycystic ovary syndrome	0.00127	0.00409	CbGeAlD
Verapamil—KCNH2—endocrine gland—polycystic ovary syndrome	0.00125	0.00405	CbGeAlD
Verapamil—CYP2C8—vagina—polycystic ovary syndrome	0.00123	0.00396	CbGeAlD
Verapamil—ABCG2—female gonad—polycystic ovary syndrome	0.0012	0.00388	CbGeAlD
Verapamil—ABCG2—vagina—polycystic ovary syndrome	0.00119	0.00385	CbGeAlD
Verapamil—CYP2B6—adrenal gland—polycystic ovary syndrome	0.00119	0.00384	CbGeAlD
Verapamil—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00115	0.00371	CbGeAlD
Verapamil—CYP3A5—female gonad—polycystic ovary syndrome	0.00111	0.0036	CbGeAlD
Verapamil—CYP3A5—vagina—polycystic ovary syndrome	0.00111	0.00358	CbGeAlD
Verapamil—CYP2B6—vagina—polycystic ovary syndrome	0.0011	0.00356	CbGeAlD
Verapamil—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00107	0.00347	CbGeAlD
Verapamil—ABCB1—embryo—polycystic ovary syndrome	0.00107	0.00347	CbGeAlD
Verapamil—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00104	0.00335	CbGeAlD
Verapamil—CYP2B6—endocrine gland—polycystic ovary syndrome	0.00103	0.00333	CbGeAlD
Verapamil—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00102	0.00329	CbGeAlD
Verapamil—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000879	0.00284	CbGeAlD
Verapamil—CYP2D6—female gonad—polycystic ovary syndrome	0.000822	0.00266	CbGeAlD
Verapamil—ABCB1—endometrium—polycystic ovary syndrome	0.000785	0.00254	CbGeAlD
Verapamil—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000777	0.00251	CbGeAlD
Verapamil—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000765	0.00247	CbGeAlD
Verapamil—ABCB1—uterus—polycystic ovary syndrome	0.000723	0.00234	CbGeAlD
Verapamil—ABCB1—pituitary gland—polycystic ovary syndrome	0.00071	0.0023	CbGeAlD
Verapamil—ABCB1—adipose tissue—polycystic ovary syndrome	0.000707	0.00229	CbGeAlD
Verapamil—ABCB1—adrenal gland—polycystic ovary syndrome	0.000634	0.00205	CbGeAlD
Verapamil—ABCB1—female gonad—polycystic ovary syndrome	0.000592	0.00191	CbGeAlD
Verapamil—ABCB1—vagina—polycystic ovary syndrome	0.000588	0.0019	CbGeAlD
Verapamil—ABCB1—endocrine gland—polycystic ovary syndrome	0.00055	0.00178	CbGeAlD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.85e-05	5.48e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	2.85e-05	5.47e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.84e-05	5.46e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.84e-05	5.46e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	2.84e-05	5.45e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	2.82e-05	5.42e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PPARG—polycystic ovary syndrome	2.81e-05	5.4e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	2.81e-05	5.39e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	2.8e-05	5.38e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.79e-05	5.37e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	2.79e-05	5.36e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	2.78e-05	5.34e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	2.78e-05	5.34e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	2.77e-05	5.33e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—POMC—polycystic ovary syndrome	2.77e-05	5.32e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—IRS2—polycystic ovary syndrome	2.76e-05	5.31e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.76e-05	5.3e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—INS—polycystic ovary syndrome	2.75e-05	5.29e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—NCOR1—polycystic ovary syndrome	2.75e-05	5.29e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.74e-05	5.27e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—GNAS—polycystic ovary syndrome	2.74e-05	5.27e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	2.71e-05	5.22e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.71e-05	5.21e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	2.71e-05	5.21e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.7e-05	5.19e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	2.68e-05	5.15e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.65e-05	5.09e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	2.64e-05	5.07e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	2.63e-05	5.05e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	2.63e-05	5.05e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	2.62e-05	5.04e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PPARG—polycystic ovary syndrome	2.62e-05	5.04e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	2.62e-05	5.03e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—NCOR1—polycystic ovary syndrome	2.61e-05	5.02e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	2.61e-05	5.01e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.6e-05	5e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—POMC—polycystic ovary syndrome	2.59e-05	4.97e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PPARG—polycystic ovary syndrome	2.59e-05	4.97e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	2.58e-05	4.95e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—INS—polycystic ovary syndrome	2.57e-05	4.95e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.57e-05	4.93e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	2.55e-05	4.91e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—POMC—polycystic ovary syndrome	2.55e-05	4.9e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	2.54e-05	4.88e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—INS—polycystic ovary syndrome	2.54e-05	4.87e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	2.53e-05	4.87e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	2.53e-05	4.86e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	2.52e-05	4.84e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PPARG—polycystic ovary syndrome	2.52e-05	4.83e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	2.5e-05	4.8e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	2.49e-05	4.78e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—POMC—polycystic ovary syndrome	2.48e-05	4.77e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CYP1A1—polycystic ovary syndrome	2.48e-05	4.76e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	2.47e-05	4.76e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—INS—polycystic ovary syndrome	2.47e-05	4.74e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	2.43e-05	4.67e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	2.43e-05	4.67e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	2.42e-05	4.65e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	2.42e-05	4.65e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	2.42e-05	4.65e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.42e-05	4.64e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—IRS1—polycystic ovary syndrome	2.41e-05	4.63e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	2.4e-05	4.61e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	2.4e-05	4.61e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	2.4e-05	4.61e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.38e-05	4.58e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.38e-05	4.58e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	2.37e-05	4.56e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	2.36e-05	4.54e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.35e-05	4.51e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	2.34e-05	4.5e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	2.34e-05	4.5e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—MTHFR—polycystic ovary syndrome	2.31e-05	4.44e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—INS—polycystic ovary syndrome	2.31e-05	4.44e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	2.29e-05	4.41e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	2.29e-05	4.39e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—TH—polycystic ovary syndrome	2.28e-05	4.38e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	2.27e-05	4.37e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	2.27e-05	4.36e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	2.26e-05	4.34e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.26e-05	4.34e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	2.23e-05	4.29e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	2.23e-05	4.29e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—AKT2—polycystic ovary syndrome	2.23e-05	4.29e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—TH—polycystic ovary syndrome	2.23e-05	4.28e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	2.22e-05	4.28e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.22e-05	4.27e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	2.22e-05	4.26e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	2.21e-05	4.24e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	2.2e-05	4.24e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PPARG—polycystic ovary syndrome	2.19e-05	4.21e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	2.17e-05	4.17e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	2.17e-05	4.17e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	2.16e-05	4.16e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—POMC—polycystic ovary syndrome	2.16e-05	4.15e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.16e-05	4.15e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	2.15e-05	4.14e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.15e-05	4.14e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—INS—polycystic ovary syndrome	2.15e-05	4.13e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	2.14e-05	4.12e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	2.14e-05	4.11e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	2.14e-05	4.11e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.13e-05	4.09e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	2.12e-05	4.07e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	2.12e-05	4.07e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	2.12e-05	4.07e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	2.12e-05	4.07e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	2.11e-05	4.06e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	2.09e-05	4.02e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	2.09e-05	4.01e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	2.08e-05	3.99e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	2.06e-05	3.96e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	2.05e-05	3.94e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	2.04e-05	3.92e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	2.02e-05	3.89e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	2e-05	3.84e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	1.99e-05	3.83e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	1.98e-05	3.8e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.98e-05	3.8e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	1.97e-05	3.79e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	1.97e-05	3.79e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.97e-05	3.79e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.97e-05	3.78e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	1.95e-05	3.76e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.94e-05	3.74e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—POMC—polycystic ovary syndrome	1.94e-05	3.74e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.94e-05	3.73e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—INS—polycystic ovary syndrome	1.93e-05	3.72e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—TH—polycystic ovary syndrome	1.93e-05	3.71e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.92e-05	3.69e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.88e-05	3.62e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	1.88e-05	3.61e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PPARG—polycystic ovary syndrome	1.87e-05	3.6e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	1.86e-05	3.58e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.86e-05	3.58e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—POMC—polycystic ovary syndrome	1.85e-05	3.55e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	1.85e-05	3.55e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—INS—polycystic ovary syndrome	1.84e-05	3.53e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.83e-05	3.52e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.83e-05	3.52e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	1.83e-05	3.51e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	1.82e-05	3.5e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	1.82e-05	3.49e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	1.77e-05	3.41e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	1.77e-05	3.39e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.76e-05	3.38e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	1.73e-05	3.33e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	1.73e-05	3.33e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—TH—polycystic ovary syndrome	1.72e-05	3.31e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	1.72e-05	3.3e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—POMC—polycystic ovary syndrome	1.71e-05	3.29e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—INS—polycystic ovary syndrome	1.7e-05	3.27e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	1.7e-05	3.26e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.69e-05	3.25e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—INS—polycystic ovary syndrome	1.69e-05	3.24e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.68e-05	3.23e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	1.68e-05	3.23e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.68e-05	3.23e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	1.68e-05	3.22e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.67e-05	3.21e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.67e-05	3.21e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.66e-05	3.19e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	1.64e-05	3.16e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.64e-05	3.15e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.63e-05	3.14e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	1.6e-05	3.07e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.59e-05	3.05e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.58e-05	3.04e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	1.58e-05	3.03e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.58e-05	3.03e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	1.58e-05	3.03e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	1.58e-05	3.03e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—TH—polycystic ovary syndrome	1.57e-05	3.02e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—INS—polycystic ovary syndrome	1.57e-05	3.02e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	1.57e-05	3.01e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.55e-05	2.98e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.54e-05	2.96e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.54e-05	2.96e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	1.53e-05	2.95e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	1.53e-05	2.94e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	1.5e-05	2.89e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.45e-05	2.8e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.45e-05	2.79e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	1.44e-05	2.76e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	1.42e-05	2.74e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.41e-05	2.71e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	1.41e-05	2.7e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.37e-05	2.64e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.36e-05	2.61e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.34e-05	2.58e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	1.34e-05	2.58e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	1.33e-05	2.55e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.31e-05	2.51e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.31e-05	2.51e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.3e-05	2.51e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.29e-05	2.49e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.29e-05	2.48e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	1.28e-05	2.47e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	1.27e-05	2.44e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	1.27e-05	2.44e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	1.25e-05	2.41e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—INS—polycystic ovary syndrome	1.25e-05	2.4e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	1.24e-05	2.39e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.24e-05	2.38e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.23e-05	2.37e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.23e-05	2.36e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	1.23e-05	2.36e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	1.22e-05	2.35e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—INS—polycystic ovary syndrome	1.22e-05	2.34e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.22e-05	2.34e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.2e-05	2.3e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	1.18e-05	2.28e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	1.17e-05	2.25e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	1.16e-05	2.23e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.16e-05	2.22e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	1.1e-05	2.11e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	1.09e-05	2.09e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	1.08e-05	2.08e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	1.08e-05	2.07e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	1.06e-05	2.04e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—INS—polycystic ovary syndrome	1.06e-05	2.03e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.04e-05	2.01e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.04e-05	1.99e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—IL6—polycystic ovary syndrome	1.01e-05	1.94e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.01e-05	1.94e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	9.9e-06	1.9e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	9.61e-06	1.85e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	9.48e-06	1.82e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	9.47e-06	1.82e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—INS—polycystic ovary syndrome	9.42e-06	1.81e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	9.38e-06	1.8e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—POMC—polycystic ovary syndrome	9.25e-06	1.78e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	9.23e-06	1.77e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—INS—polycystic ovary syndrome	9.2e-06	1.77e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	8.84e-06	1.7e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	8.76e-06	1.68e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	8.71e-06	1.67e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—INS—polycystic ovary syndrome	8.67e-06	1.67e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	8.64e-06	1.66e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—INS—polycystic ovary syndrome	8.59e-06	1.65e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	8.46e-06	1.63e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	8.06e-06	1.55e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	7.64e-06	1.47e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	7.49e-06	1.44e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	7.38e-06	1.42e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—INS—polycystic ovary syndrome	7.34e-06	1.41e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	7.12e-06	1.37e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	5.78e-06	1.11e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	5.7e-06	1.09e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—INS—polycystic ovary syndrome	5.67e-06	1.09e-05	CbGpPWpGaD
